<DOC>
	<DOCNO>NCT01258491</DOCNO>
	<brief_summary>The study double-blind , randomize , placebo-controlled , single-center , 2 treatment,3-way crossover investigate pharmacodynamics , i.e . flush-symptom single oral repeat dose 500 mg nicotinic acid healthy subject . Subjects randomly allocate treatment sequence - AAB , ABA BAA . The two treatment : - Treatment A : 500 mg nicotinic acid - Treatment B : Placebo</brief_summary>
	<brief_title>Study Investigate Pharmacodynamics , Pharmacokinetics Safety Single Oral Repeated Dose 500 mg Nicotinic Acid Tablets Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Body weight 50 90 kg body mass index 19 &lt; 30 kg/m2 No clinically relevant finding medical history , laboratory examination physical examination , especially regard cardiovascular system , liver function test , bilirubin value skin No clinical relevant pathological finding electrocardiogram ( ECG ) Normal blood pressure ( BP , syst . 100 140 mmHg , diast . 60 90 mmHg ) pulse rate ( 50 90 beats/min ) sit position Voluntarily sign informed consent full explanation study participant Treatment investigational product last 60 day day randomization study Regular use medication last 60 day day randomization study except oral contraceptive female participant Treatment 60 day day randomization study drug know welldefined potential toxicity major organ , substance know induce inhibit hepatic drug metabolism ( include general anesthetic ) Any drug intake ( include overthecounter remedy ) 2 week day randomization study , unless investigator considers drug intake clinically irrelevant purpose study Any acute chronic illness clinically relevant finding prestudy examination Presence , history sequelae gastrointestinal ( e.g . peptic ulcer ) , liver kidney disease , condition know interfere absorption , distribution , metabolism excretion drug History hypersensitivity investigational product History presence abnormality vascular bed History presence dermatologic disease skin lesion , particular area choose flush measurement History allergy hypersensitivity drug food constituent History allergic diseases hypersensitivity , unless investigator considers clinically irrelevant purpose study Blood donation &gt; 400 ml 60 day day randomization study Smoking Positive result urine screen drug abuse alcohol breath test Known suspect drugdependent , include consumption &gt; 30 g alcohol per day Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>